Genome Editing Market ANALYSE DE LA TAILLE ET DU PARTAGE - TENDANCES DE CROISSANCE ET PRÉVISIONS (2024 - 2031)

Genome Editing Market is segmented By Type of Gene Editing Technique (CRISPR-Cas System, TALENs, Meganucleases, ZFNs, Other Techniques), By Type of Therapy (Cell Therapies, Gene Therapies, Other Therapies), By Gene Editing Approach (Gene Knock-Out Approaches, Gene Knock-In Approaches), By Gene Delivery Method(Ex-Vivo Delivery Methods, In-Vivo Delivery Methods), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD billion) for the above-mentioned segments.

Competitive overview of Genome Editing Market

Les principaux acteurs du marché de l'édition génomique sont le CRISPR Therapeutics, Editas Medicine, Intellia Therapeutics, Beam Therapeutics, Caribou Biosciences, Arcturus Therapeutics, Century Therapeutics, Graphite Bio, Prime Medicine et Vor Biopharma.

Genome Editing Market Leaders

  • CRISPR thérapeutique
  • Editas Médecine
  • Intellia Thérapeutique
  • Beam Thérapeutique
  • Biosciences du caribou
*Disclaimer: Major players are listed in no particular order.

Genome Editing Market - Competitive Rivalry, 2023

Market Concentration Graph

Genome Editing Market

Market Consolidated
(Dominated by major players)
Market Fragmented
(Highly competitive with lots of players.)
*Source: Coherent Market Insights